Page last updated: 2024-11-05

ticlopidine and Inflammatory Bowel Diseases

ticlopidine has been researched along with Inflammatory Bowel Diseases in 2 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Inflammatory Bowel Diseases: Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Singh, S1
Kullo, IJ1
Pardi, DS1
Loftus, EV1
Vinod, J1
Vadada, D1
Korelitz, BI1
Sonpal, N1
Panagopoulos, G1
Baiocco, P1

Reviews

1 review available for ticlopidine and Inflammatory Bowel Diseases

ArticleYear
Epidemiology, risk factors and management of cardiovascular diseases in IBD.
    Nature reviews. Gastroenterology & hepatology, 2015, Volume: 12, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Clopidogrel; Endothelium,

2015

Other Studies

1 other study available for ticlopidine and Inflammatory Bowel Diseases

ArticleYear
The effect of antiplatelet therapy in patients with inflammatory bowel disease.
    Journal of clinical gastroenterology, 2012, Volume: 46, Issue:6

    Topics: Aspirin; Clopidogrel; Disease Progression; Female; Humans; Inflammatory Bowel Diseases; Male; Platel

2012